Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease - Saglimbene, VM - 2017 | Cochrane Library https://t.co/9uzxDuvYbs
RT @CochraneKidney: Continuous erythropoiesis receptor activator for the anaemia of CKD https://t.co/fIrKU54mVi https://t.co/o3g3b05FWM
Another example of why CKD is a hopeless term and should be changed? https://t.co/exvf8tThBN
RT @CochraneKidney: New #CochraneReview: Continuous erythropoiesis receptor activator (CERA) for the anaemia of CKD https://t.co/HRWFEpiRuN…
#Cochrane_Publica #Rev_Sist Metoxi-PEG-epoetina beta #CERA en #anemia en #Enfermedad_renal_crónica https://t.co/BGjXV6FAZ2 @SENefrologia
RT @set_fortess: Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney pt https://t.co/ctG63tMcaM
Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney pt https://t.co/ctG63tMcaM
CERA treatment for anaemia in people with chronic kidney disease https://t.co/5OX8L3PxS8
RT @CochraneKidney: New #CochraneReview: Continuous erythropoiesis receptor activator (CERA) for the anaemia of CKD https://t.co/HRWFEpiRuN…
CochraneLibrary: CERA treatment for anaemia in people with chronic kidney disease https://t.co/CCyMZVsqH5 https://t.co/w4iaiQv49S
Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney… https://t.co/7ZM3Lf3LWn
RT @CochraneKidney: New #CochraneReview: Continuous erythropoiesis receptor activator (CERA) for the anaemia of CKD https://t.co/HRWFEpiRuN…
New #CochraneReview: Continuous erythropoiesis receptor activator (CERA) for the anaemia of CKD https://t.co/HRWFEpiRuN https://t.co/28EVC7nY0B